The evolution of bladder cancer genomics: What have we learned and how can we use it?

doi:10.1016/j.urolonc.2018.02.017

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The evolution of bladder cancer genomics: What have we learned and how can we use it?

Urologic oncology - 1 Jul 2018

Audenet François, Attalla Kyrollis, Sfakianos John P

Abstract excerpt

BACKGROUND: With advancements in molecular biology techniques, great progress has been made in the understanding of urothelial carcinoma pathogenesis. OBJECTIVE: To examine the historic description of molecular alterations in bladder cancer and their evolution towards our current comprehension of the biology of the disease. RESULTS: Historically, a two-pathway model was described from histological and cytogenetic...

Topics

Biomarkers, Tumor
Genome, Human
Genomics
Humans
Mutation
Prognosis
Signal Transduction
Urinary Bladder Neoplasms

Source

Open in PubMed

Identifiers

PMID: 29573965
DOI: 10.1016/j.urolonc.2018.02.017

Genes

FGFR3
TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics